Search for: "Novartis LLC"
Results 61 - 80
of 183
Sort by Relevance
|
Sort by Date
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
19 Mar 2015, 4:57 pm
Supp. 2d 589) begins:On January 14, 2011, plaintiff Butamax™ Advanced Biofuels LLC ("Butamax") filed suit in this district against defendant Gevo, Inc. [read post]
3 Mar 2015, 1:55 am
Counsel for Pfizer drew analogy between this situation and “the situation where an injunction is sought pending appeal even though the patent has been held invalid at first instance, as to which see Novartis AG v Hospira UK Ltd [2013] EWCA Civ 583, [2014] 1 WLR 1264. [read post]
2 Mar 2015, 2:43 pm
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems& Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
23 Feb 2015, 2:55 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
16 Feb 2015, 1:44 am
* Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
15 Feb 2015, 9:43 pm
• Defendant: Ezra Ventures LLC Novartis AG et al. v. [read post]
9 Feb 2015, 1:15 am
* Warner-Lambert v Actavis Mark 2, still at first instance: more on Swiss claims, Skinny Labels, and no StrikeoutDarren covers another Arnoldian decision in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 223 (Pat). [read post]
2 Feb 2015, 2:20 am
* Dutch diverge with English as Novartis prevails on Zoledronic Acid in NetherlandsKatfriend Rutger M. [read post]
25 Dec 2014, 10:25 am
Novartis Pharm. [read post]
18 Dec 2014, 8:52 am
Euro-Pro Operating LLC., No. 14-2767 (3d Cir. [read post]
7 Nov 2014, 5:52 am
APP Pharmaceuticals, LLC, 2013 WL 5532767, at *7-8 (D. [read post]
12 Oct 2014, 8:11 am
Novartis Pharm. [read post]
12 Mar 2014, 12:43 pm
Actavis South Atlantic LLC, et al., C.A. [read post]
19 Feb 2014, 6:57 am
• Novartis Pharmaceuticals Corporation • Pfizer, Inc. [read post]
3 Feb 2014, 9:51 pm
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
20 Aug 2013, 7:57 am
Novartis Pharms. [read post]
Judge Robinson grants motion for leave to amend complaint 9 months after deadline to amend pleadings
26 Jul 2013, 7:48 am
Medimmune, LLC, et al., C.A. [read post]
21 Jun 2013, 4:12 pm
It was joined by Novo A/S as co-lead as well as existing investors Novartis Venture Funds, Kearny Venture Partners, Venture Investors LLC, Athenian Venture Partners, Triathlon Medical Ventures, AgeChem Venture and Sigvion Capital Fund. [read post]
21 Jun 2013, 4:12 pm
It was joined by Novo A/S as co-lead as well as existing investors Novartis Venture Funds, Kearny Venture Partners, Venture Investors LLC, Athenian Venture Partners, Triathlon Medical Ventures, AgeChem Venture and Sigvion Capital Fund. [read post]
